Democratic People s Republic of Korea

Size: px
Start display at page:

Download "Democratic People s Republic of Korea"

Transcription

1 National TB prevalence survey Democratic People s Republic of Korea

2

3 Technical Brief TB National Prevalence Survey Democratic People s Republic of Korea

4

5 Contents Acknowledgement...iv Acronyms...v Executive summary... vii 1. Introduction Trend of TB prevalence in DPR Korea National TB Prevalence Survey Survey results Survey participation by sex and age Survey participation by Urban, Rural and Regions Occupation distribution of survey participants Smoking status among the survey participants Contact status with known TB cases Screening Laboratory examination TB cases Success, challenges and lessons learnt from survey design to finalization of survey result...18 iii

6 Acknowledgement The achieved success is due to NTP s contribution of USD to the survey and the comparative use of less external funds (USD from Global Fund) than other Asian countries for a successful implementation of National TB Prevalence Survey. Technical assistance for countries which do not have any past survey experience is essential during the survey preparation, field operation and data analysis. In country, the UNICEF country office was responsible for the procurement and WHO country office provided the technical support for protocol development, field operation, final data analysis and report preparation. Through the WHO support, technical consultant who was involved in the Indonesian National TB Prevalence Survey visited DPR Korea in June 2016, reviewed survey implementation and provided technical support for data analysis. In the end of July 2016, two lab experts from Hong Kong SNRL reviewed the laboratory progress and validated survey lab results. In 2017, WHO HQ experts reviewed the whole survey database two times and provided the technical support for a joint survey data review and final analysis. iv

7 Acronyms AFB-S BSC C&DST CDMU CI CNR CP CPC CTPI CXR DM DOT DOTS DPR Korea DRTB DR-TB EA EQA FLD FM GFATM HIV IP IPW KAP L-J M & E Acid-fast bacilli smear Biosafety cabinet Culture and drug susceptibility testing Central data management unit Confidence interval Case notification rates Continuation phase Cetylpyridinium chloride Central TB Preventive Institute Chest X-ray Diabetes mellitus Directly Observed Treatment Directly observed treatment short course Democratic People s Republic of Korea Drug-resistant tuberculosis Drug resistant TB Enumeration area External quality assurance First Line Drugs Fluorescent microscopy The Global Fund to fight AIDS, Tuberculosis and Malaria Human immunodeficiency virus Intensive phase Inverse probability weighting Knowledge, attitude and practice Lowenstein Jensen Monitoring and evaluation v

8 MDGs MDR-TB MI MoPH MOTT MTB NA NPS NRL NTM NTP OR PIN PMU PPS PR PTB PTPI RSE SD SE SLD SNRL SOP TA TAG TB UNICEF WHO ZN Millennium Development Goals Multidrug-resistant tuberculosis Multiple imputation Ministry of Public Health Mycobacterium other than tuberculosis Mycobacterium tuberculosis Not available National TB Prevalence Survey National TB Reference Laboratory Non Tuberculosis Mycobacterium National Tuberculosis Control Programme Odds ratio Personal identification number Project Management Unit Probability proportional to size Principal Recipient Pulmonary tuberculosis Provincial TB Preventive Institute Relative standard error Standard deviation Standard error Second-line drugs Supra national reference laboratory Standard operating procedure Technical assistance Technical advisory group Tuberculosis United Nations Children s Fund World Health Organization Ziehl-Neelsen vi

9 Executive summary The National Tuberculosis (TB) Prevalence Survey conducted in DPR Korea ( ) aimed at understanding the real burden of the TB disease within the country and finding ways to improve TB detection and control activities. This is the first nationwide TB prevalence survey in DPR Korea. The National TB Prevalence Survey is cross-sectional survey utilizing multi-stage sampling methods. Multi-stage sampling methods include the stratified sampling method and the random cluster sampling method. The capital of DPR Korea is Pyongyang city and the country is geopolitically split into nine provinces and three municipalities, which are then divided into 210 cities and counties. Counties are subdivided into almost 4000 smaller administrative areas such as Ri, Ub, Gu and Dong. Survey clusters for the National TB Prevalence Survey were selected throughout the entire country with the exception of Jagang Province. There was no major sex ratio difference found with the survey census data when compared with the national data published by Central Bureau of statistics in 2015, There were a total of 100 survey clusters with a total eligible survey population out of which were the eligible survey participants after excluding children population under 15 years of age. The prevalence survey identified high levels of TB overall, highlighting that TB remains a public health concern in DPR Korea. Based on the survey results, the estimated national TB prevalence rate (in all forms and among all ages) is 641 as per populations. This estimation is 1.31 times higher than 2012 national TB prevalence rate estimation (490 cases per population) when the National TB Prevalence Survey design was conducted and 1.25 times higher than WHO estimation (511 cases per population). In the National TB Prevalence survey, a total of 356 bacteriologically confirmed pulmonary TB cases were detected, out of which 340 cases were confirmed as survey TB cases based on the follow up results and central expert committee discussion. Among the 356 bacteriologically confirmed pulmonary TB cases, 247 persons (69.4%) were males and 109 persons (30.6%) were females. The sex ratio of smear vii

10 positive pulmonary TB cases was 2.4:1 and that of bacteriologically confirmed pulmonary TB cases were 2.3:1. This result shows that survey result is almost similar to past NTP notification data. Among 203 smear positive cases, 16 cases with culture negative results were excluded from the survey TB cases based on the central expert committee s decision. Therefore there was a total of 340 survey TB cases, out of which 187 were smear positive TB cases and 153 were smear negative TB cases. Among the smear positive TB cases, the culture positive was 84.5% and the culture negative was 15.5%. Among the smear negative TB cases, the culture positive was 39.2% and scanty culture was 60.8%. There were a total of 760 cases that had missing lab results (those who did not produce sputum samples or cultures are contaminated). Such cases have been taken into account and multiple imputations applied for calculating the final TB prevalence. Among the survey TB cases, 187 cases (55.0%) were detected both by interview and chest X-ray. 146 cases (42.9%) were screened only by chest X-ray. 7 cases (2.1%) were suspected as a TB case by interview alone. Among these 7 cases, 5 persons could not undergo chest X-ray. Among the 187 smear positive cases, 62.6% were identified both by interview and chest X-ray, while 34.2% were identified by chest X-ray alone and 3.2% by interview alone. This result shows that there is high probability of getting TB in TB suspects identified both by interview and CXR. Distribution of survey TB cases by sex was 69.7% of males and 30.3% of females. In males survey TB cases were found 2.3 times higher than in females. Survey TB cases increased with age until 55 years. Based on the survey TB cases and the number of survey participants, the survey team calculated the prevalence of bacteriologically confirmed pulmonary TB among 15 years and above population as 567 per population ( ). As per WHO recommendation, the team used model 3 with the survey data to estimate TB prevalence. First the survey team conducted multiple imputations for missing cases and applied inverse probability weighting to the eligible non participants and no sputum collection candidates for TB prevalence estimation. The result was 587 per population. viii

11 Prevalence of males is 2.9 times higher than that of females and in age group it was highest as 877 per population. TB prevalence in rural area is 1.14 times higher than in urban areas. After applying the sex proportion weighting to the eligible population in the country, the result was 597 per populations. Proportion of males among enumerated population was 44.8% and among national population it was %( excluding army), thus weighting for males have been made. Given that the proportion of under 15 years of age population is 20.7% and ratio of pediatric TB prevalence to adult TB prevalence is 26.6% and proportion of extrapulmonary cases is 21% by using last 5 years of NTP notification data, TB prevalence of all age, all forms is estimated as 641 per population. 1.27% of smokers were identified as survey TB cases, which was 3 times higher than the proportion of survey TB cases among non-smokers (0.43%). This result shows that smoking is one of key risk factors for TB and explains why the TB prevalence in males is much higher than the one in females in the country. Among the survey participants who had contact with TB case in family, 3.76% were confirmed as survey TB cases, which was 7.7 times higher than those who did not have TB case in family. 2.91% of survey participants who had contact with TB case were diagnosed as survey TB case with a rate of 6.3 times higher than those who did not have any contact with TB case in past two years. ix

12 x

13 1 Introduction Throughout the world, TB is a disease with a high incidence rate and high rate of mortality among infectious diseases. Due to the vicious strategy of isolation and squeezing by the USA and its satellite countries, and natural disasters occurring in rapid succession, TB emerged once again as a high-burden disease in the country. The first step for treatment and prevention of TB is to identify the negative effect of TB on the public health sector with an emphasis on identifying the TB epidemiological situation in the country. Knowing the precise situation of TB epidemiology in the country is of high importance for the evaluation on the current implementation status of TB control strategy and for further development of the succeeding TB control strategy. Previous evaluation on the case notification rate, treatment success rate and regional TB epidemiology had been conducted for some years based on the number of estimated TB cases from Annual Risk of Tuberculosis Infection (ARTI), though some discrepancies were observed in the evaluation and some questions rose about the reliability of ARTI estimations of TB cases. Therefore, despite the high survey cost, many countries planned and conducted National TB Prevalence Surveys to more accurately estimate the number of TB cases. As a result the countries made a strong improvement in case detection, registration and management, achieving beyond what was expected. The MoPH of DPR Korea decided to conduct a National TB Prevalence Survey using a sampling method representative of the whole country in order to establish the precise situation of TB epidemiology in the country and to organize TB prevention and treatment in a scientific way. This was the first time in the country to conduct national TB Prevalence Survey. Therefore, DPR Korea evaluated the experience of other country surveys, adopted WHO-recommended survey methodology and developed all survey forms, SOPs and processes of data analysis specific to country context. Based on the preparation, we conducted the National TB Prevalence Survey successfully. 1.1 Trend of TB prevalence in DPR Korea To estimate the real burden of disease caused by TB in the entire country, DPR Korea National TB Control Programme (NTP) conducted the Annual Risk of Tuberculosis 1

14 Infection (ARTI) survey under WHO technical support in The ARTI of DPR Korea was thus estimated at 3.1% (2.8~3.3%). Based on this result the new smear positive TB cases were estimated at 155±34 per population. According to the WHO Global TB Report published in 2011, the estimate for all forms of TB in DPR Korea was (72 000~97 000) and TB incidence was estimated at 345 (100~698) per population in Death due to TB was estimated at 5700 (4100~9400) giving TB a mortality rate of 23 (17~39) per population. In 2011, NTP in DPR Korea reported that notifications for all forms of TB cases were 386 per population and TB notification for new smear positive TB were 134 cases per population. 1.2 National TB Prevalence Survey Survey objectives Primary objective The National TB Prevalence Survey in DPR Korea ( ) aimed to have a new understanding of the real burden of disease caused by TB and to find solutions to improve TB control activities. Secondary objectives To measure bacteriologically confirmed pulmonary TB among population aged 15 years and above in DPR Korea. To re-estimate TB burden (TB prevalence and mortality) by comparing survey results with previous TB prevalence estimation and notification data and to set the baseline for assessing trends in TB disease burden. To assess the proportion of people with TB symptoms. To evaluate the relationship between social, demographic, health factors and TB. To measure the CXR epidemiology suggestive of TB among the adult population Sampling method 3 tier/stage stratified multistage cluster samplings were used. First, the country was stratified into urban and rural areas. Second, urban and rural areas were divided 2

15 into east coast region, west coast region and in-land region separately. Thirdly, all administrative units were enumerated and clusters were selected according to probability proportional to size (PPS) sampling. The eligibility criteria for the survey were as follows: Individuals aged 15 years. The prevalence of smear positive pulmonary TB among those aged <15 was very low. In DPR Korea, more than 90% of smearpositive pulmonary TB cases developed from the adults aged 15 years, plus it was difficult to collect sputum samples from children. Individuals resided in flats in a peripheral administrative unit for more than 2 weeks (All residents were registered in their living administrative unit 2 weeks before the survey census) Reception of survey participants From households in the community. The exclusion criteria for the survey were as follows: Travelers staying at hotels and hospitalized individuals in survey areas: The chance of collecting samples from these individuals was very rare. Moreover, travelers could not be representative of resident people in the survey population. Individuals serving in the army and security forces: These individuals were the same sex and cannot represent the survey population. Prisoners Screening A screening method recommended by WHO was used. Participants suspected of having TB either by chest X-ray or by the interview were examined using sputum smear microscopy and culture. 3

16 Figure 1: Survey Screening Interview, Chest X-ray Normal (Interview, Chest X-ray) Abnormal (Interview, Chest X-ray) No Smear microscopy & Culture Smear microscopy & Culture The eligibility for sputum collection in terms of chest X-ray was defined as all those with an abnormal chest radiograph in the lung field or mediastinum other than a single small calcification nodule with a size less than 10 mm or pleural adhesion at costo-phrenic angle(s). Even if there were abnormal findings incompatible with TB such as bronco-pneumonia or bronchiectasis, sputum collection was requested for the purpose of screening. The team leader interpreted all films taken that day the same night for quality assurance. The final decisions from the survey TB cases were made by a central expert committee referencing the screening data Survey implementation The survey implementation and refinement underwent an Assessment visit, Pre-survey visit, Pilot survey before the actual Field operation Phase 1 of the field operation was conducted from Oct to Dec 2015 and Phase 2 from Feb to May During Phase 1, two field teams conducted the field operation in 16 clusters within Pyongyang city and during phase 2, six field teams undertook the operation within the remaining 84 clusters nationwide. Pilot Survey at Kaesong Dong, Morangbong District 4

17 1.2.5 Quality assurance measures The protocol was designed in line with WHO guideline and reviewed by WHO Task Force Members on several occasions. Regular and mid-term monitoring was conducted throughout field implementation Survey field operation Symptom Screening Doctors in the interview unit undertook careful interviews with survey participants and recorded their answers to the Questionnaire. X-ray screening The X-ray reader interpreted the film carefully to discern whether it had any abnormal shadow and recorded the findings of the film in the section of Field reading. Primary field results were classified into three types: Normal, Abnormal, and Not taken. Participants with abnormal chest X-ray results were identified to produce sputum samples, as did elderly, pregnant and disabled participants who did not take chest X-ray but had symptoms suggestive of TB. The team leader interpreted all films taken that day the same night for quality assurance. If there was any discrepancy, a sputum collection was requested for suspected participants before the team left. Sputum collection and field report The early morning sputum and spot sputum from eligible survey participants through the network of household doctors were collected and packaged for transportation to NTRL. Central survey operation Under the leadership of the steering committee for the National TB Prevalence Survey, the central survey operation Sample collection at field 5

18 composed of laboratory work, final interpretation and organization of the technical advisory groups, and data management including categorization, input and analysis of data, and quality assurance. Laboratory All laboratory tests of Mycobacterium tuberculosis were performed at National tuberculosis Reference Laboratory with biosafety equipment and experienced laboratory staff in the Central Tuberculosis Preventive Institute. All laboratory materials infected by M. tuberculosis were incinerated or autoclaved for reuse. Sputum smear microscopy All sputum specimens transported by the field survey teams were put through a decontamination processed by using N-acetyl-L-cysteine sodium hydroxide (NALC- NaOH). Smear samples were prepared according to the ID number and an AFB microscopy was performed after fluorescent staining. The results of sputum smear microscopy are recorded as follows: Culture Examination After processing sputum samples and preparing smears, deposits were inoculated with 3 4 drops (approximately ml) on slopes of egg-based medium labelled with the ID number. Contaminated cultures were removed and rapidly growing mycobacteria were identified using SD Bioline testing. Contaminated cultures were recorded when detected. Identification Test The identification of MTB was performed by SD Bioline TB Ag MPT64 rapid test with cultures. Culture at NRL, CTPI (Note: SD TB Ag MPT64 rapid test have a 10 5 CFU/ml detection limit, so TB confirmation can be available with only 3 colonies from an early stage of culture (around 3 4 weeks)). 6

19 Re-checking of slides When a specimen turned out to be smear-negative but culture-positive, the slide derived from the specimen was rechecked with FM in order to avoid the false-negative smear result and verify the original smear result. Final interpretation of X-ray films All the chest X-ray films taken in the field were sent for central reading to CTPI after each field operation. Quality assurance of laboratory tests The protocol was designed in line with WHO guideline and reviewed by WHO Task Force Members on several occasions. Regular monitoring and mid-term monitoring were performed to avoid inter-survey team bias, including inter-lab (among lab facilities). For internal quality assurance of smear microscopy, 5~10% of positive slides were routinely rechecked. To prevent false positive smear results, rechecking all smear positive slides was performed by the referee of National Tuberculosis Reference Laboratory (NRL). To prevent false negative smear results, all smear negative slides with culture positive were rechecked by the referee of NRL. 7

20 2 Survey results 2.1 Survey participation by sex and age Among the eligible population, survey participants were and actual survey participant rate was 84.4%, almost reaching the target of 85%. By sex, male participants were (83.9%) and female participants were (84.9%). Participation rate in females was 1% higher than the one in female. Out of the female participants 123 (0.35%) females were pregnant. Individuals enumerated in Census Eligible study population (79.45%) Ineligible individuals: (20.55%) Excluding Children& Adult due to residential criteria Participants (84.4%) -Interview only (1.7%) -Interview and CXR (98.3 Eligible for Sputum Examination (7.9%) Submitted at least one specimen (95.5%) Submitted two specimens (92.5%) Symptom + CXR + : 1 028(21.4%) Symptom + CXR -: 1 916(39.9%) Symptom - CXR - : 1 858(38.7%) Missed cases: 216 (4.5%) Lab Results available (95.5% of eligible) (2 Smear 2 Culture results: 4 037, 84.1%) Any Smear Positive 212 Morning S+ only: 39 Spot S+ only: 14 Both S+: 159 Any Smear Negative: Morning S- only: 56 Spot S- only: 121 Morning S- & Spot S-: Culture result MTB MOTT+ 9 Contaminated 1 Negative 44 Culture result MTB MOTT+ 1 Contaminated 1 Negative 44 Smear + Culture Smear + Culture -: 29 Smear + Culture + (NTM):9 Smear + Culture ND/contained: 1 Smear - Culture +:153 Smear not done, Culture +: (NTM):1 Positive Bacteriological MTB result: 340 Central Panel S+ C+ 158 S+ C- 29 MOTT 9 Excluded cases 16 S- C+ 153 MOTT 1 Excluded cases 3964 Culture contamination rate: Spot: 220/4 504=4.9% Morning: 208/4 544=4.6% 8

21 Figure 2: Sex and age of eligible population VS survey participation Male Female Age group Number Eligible Participants 2.2 Survey participation by Urban, Rural and Regions Survey participation rate in urban and rural areas were 83% and 84.95% respectively, which was higher in rural area than in urban area. Participation rate in construction units was 98.3%. 2.3 Occupation distribution of survey participants The occupational distribution among participants were 30.2% of workers, 21.8% of farmers, 10.4% of officers, 8.1% of students, 0.03% of sports players and 29.6% of the dependent and retired 2.4 Smoking status among the survey participants 18.3% of survey participants ( persons) were identified as smokers, out of which was male smokers and 8 was female smokers. Smoking rate among male participants was 41.1%, while female smoking rate was 0.02% close to 0%. 0.11% of participants (69 persons) stopped smoking. Male smoking rate increased with age. 9

22 2.5 Contact status with known TB cases 100% of survey participants answered to question of any TB cases in their family and 1485 participants (2.8%) responded having TB case in their family. There was no significant difference between male and female responses. Table1.1: Proportion of survey participants who have TB patients in family within the past two years (%) Sex No TB case in family TB case in family N % N % Male Female Total % of participants answered the question relating to any contact history with Pul-TB cases within the past two years. Among those responders, 3089 persons (5.1%) responded they had a history of contact with Pul-TB cases. It was noted that there were more contacts in males (5.9%) than in females (4.4%). There were nonresponders of 82 females and 45 males. 2.6 Screening Interview 85.1% of survey participants did not have any symptoms and only 14.9% of survey participants had at least one symptom. Among the participants who had the positive symptoms, the males was 18.7% and the females was 11.9%. Among the positive symptoms, 10.1% was cough, 7.5% was breathless, 6.7% was sputum, 2.3% was ineffectualness, 2.2% was fever, 2% was night sweating with other symptoms being less than 2%. Males had 1.3 or 2.3 times more symptoms than females TB presumptive cases by interview and CXR In survey protocol, those who have more than 15 days of cough/hemoptysis/blood in sputum/abnormal chest X-ray were defined as TB presumptive cases. 10

23 Through the interview and Chest X-ray, 7.9% of the total survey participants (4802 persons) were identified as sputum collection candidates. Among them, 3.2% were identified by interview only, 3.1% by CXR only and 1.7% by both of interview and CXR. Differences in the sex variable were identified, where 10.8% of male survey participants and 5.6% of female survey participants were screened positive. Male presumptive cases were 2 times higher than the female presumptive cases. The TB presumptive cases increased with age except for the over 55 s with lower trend. No significant difference was identified by the stratums. There were more TB presumptive cases in rural areas than in urban areas. By provinces, proportion of TB presumptive cases among the survey participants ranged from 4.8% to 11%. 2.7 Laboratory examination Smear result The spot sputum was collected from 4544 survey participants (94.6% of TB presumptive cases) and morning sputum was collected from 4504 survey participants (93.8% of TB presumptive cases). Among spot sputum providers, 164 persons had positive smear results with 34.1% of scanty, which was 3.6% of survey participant who produced spot sputum. Among morning sputum providers 189 persons had positive smear results with 36.5% of scanty, which equaled to 4.2% of morning sputum providers. 14 persons had only positive spot smear results and 39 persons had only positive morning smear result. 150 persons had positive smear result both by spot and morning sputum. Thus, a total number of smear positive cases was 203 persons, out of which 73.9% were positive both by spot and morning sputum and only 26.1% positive either by morning or spot sputum 216 persons did not submit either spot or morning sputum (4.5% of TB presumptive cases) Culture result Culture test was done for all collected sputum samples. 5.7% of spot sputum were culture- positive and 6.5% of morning sputum were culture-positive. 0.2% of samples were NTM and contamination rate was 4.6% and 4.95% respectively. 11

24 16 persons had culture positive results by spot sputum only, 50 persons culturepositive by morning sputum only and 245 persons were culture-positive both by morning and spot sputum. The total number of culture positive cases was 311 persons. Among the culture-positive results, 78.8% was positive both by morning and spot sputum and 21.2% was positive either by morning or spot specimen. Among culture-positive results of spot sputum, 34.5% was scanty and among the culture-positive results of morning sputum 41.4% was scanty Comparison of Smear and Culture result Among 164 spot smear positive cases, 36 persons (21%) had culture negative results and one sample had been contaminated. Other 127 persons were spot smear positive & culture positive. This meant that spot smear and culture positive results were 42.64% of the spot smear positive results. Among 4371 spot smear negative cases, 134 persons (3.1%) were culture positive cases. When combining spot smear and culture results, a total of 298 persons were either spot smear-positive or culture positive. Out of 208 contaminations, 207 were smear negative and only 1 was smearpositive. Among 189 morning smear positive cases, 37 persons (21%) had culture negative results and 147 persons were morning smear positive& culture positive. This meant that morning smear and culture positive results were 44.3% of the morning smear positive results. Among 4306 morning smear negative cases, 148 persons (3.4%) were culture positive cases. When combining morning smear and culture results, a total of 322 persons were either morning smear positive or culture positive. Out of 220 contaminations, 5 were smear-positive. 12

25 2.8 TB cases Definite and Probable TB cases Out of 203 smear positive cases, 16 persons were identified as culture negative cases in the follow-up, thus 16 participants were excluded from survey TB cases by Central expert committee. The central expert committee confirmed 187 smear positive TB cases and 153 smear negative TB cases, therefore a total of bacteriologically confirmed TB cases were 340. Among the smear positive TB cases, 84.5% were culture positive and 15.5% were culture negative TB cases. Among the smear negative TB cases, 60.8% were culture positive and 39.2% were culture scanty TB cases. There were 760 persons who were eligible for smear examination, but didn t produce sputum samples or contaminated during lab examination. Therefore missing value imputation was done for 760 cases for estimation of TB prevalence Survey TB case by screening result Among the survey TB cases, 55% were confirmed by both interview and CXR. 42.9% of survey TB cases were screened positive only by CXR. 2.1% of survey TB cases were confirmed only by interview. Among the smear positive TB cases, 62.6% were confirmed by both interview and CXR. 34.2% of survey TB cases were screened positive only by CXR. 3.2% of survey TB cases were confirmed only by interview. This shows that CXR is very important tool for detection of TB cases. 13

26 Table 2: Survey TB cases by interview and CXR results Clarification Smear positive Bacteriologically positive N % N % Symptom positive, CXR Normal Symptom positive, CXR abnormal Symptom negative, CXR Abnormal Symptom positive, CXR not done Total Distribution of survey TB case by characteristics Distribution of survey TB cases by sex was 69.7% of males and 30.3% of females. Survey TB cases of males was two times higher than that of females. After 55 years of age band, the number of TB cases decreased. There were more TB cases in urban than in rural areas. Table 3: TB case distribution by sex, age, urban and rural Clarification Number of TB case Total 340 Male 237 Female 103 Age Urban 194 Rural 143 Construction unit 3 14

27 2.8.4 Final CXR reading result and survey TB case Field CXR reading results showed that 4.8% had abnormal results. Comparing the field and final CXR results, 72.3% of abnormal CXR results at field was assessed as normal at final reading and 13.3% of active pulmonary TB, 2.8% of suspected TB, 7.8% of scars after TB lesions were related to TB by final CXR reading. When analyzing survey TB cases by final CXR result, 75.6% had active pulmonary TB lesion, 14.4% was suspected having TB and 5.9% had scars after TB at final CXR reading. Only 0.6% of those having normal CXR result at final reading was identified as survey TB cases TB prevalence Based on the survey TB cases and the number of survey participants, the survey team calculated the prevalence of bacteriologically confirmed pulmonary TB among 15 years and above population as 567 per population ( ). As per WHO recommendation, the team used method 3 with the survey data to gain an estimation of TB prevalence. First the survey team conducted multiple imputations for missing cases and applied inverse probability weighting to the eligible non participants and no sputum collection candidates for TB prevalence estimation. The result was 587 per population. Prevalence of males is 2.9 times higher than that of females and in age group it was highest as 877 per population. TB prevalence in rural area is 1.14 times higher than in urban areas. After applying the sex proportion weighting to the eligible population in the country, the result was 597 per populations. Pa: National Pulmonary TB prevalence rate Pa = ( ) per population (Annual report of DPR Korea Central Bureau of Statistic: for the weighting of male and female variables, we used the national data of CBS (male population is 46.54% except military). Survey census data was 44.8% for male population). P= (1 c+cr)/(1 e) Pa P: all age, all forms of national TB Prevalence rate, 641 per populations 15

28 c: proportion of less than 15 years of age population; 20.7% r: ratio of pediatric TB prevalence to adult TB prevalence; 26.6% e: Proportion of extra-pulmonary cases; 21% The team estimated the national TB prevalence rate at 641 per populations. Table 4: Prevalence of bacteriologically confirmed pul-tb cases per age, sex, urban and rural area among 15 years and above population Cluster level analysis, Model-1 Individual level analysis, Model-2 Individual level analysis, Model-3 Clarification Prevalence ( population) (95%CI) Prevalence ( population) (95% CI) Prevalence ( population) (95% CI) Total 567( ) 582( ) 587( ) Male 892( ) 908( ) 917( ) Female 309( ) 320( ) 319( ) Age (72 220) 161( ) 155(70 240) ( ) 534( ) 579( ) ( ) 753( ) 764( ) ( ) 839( ) 877( ) ( ) 611( ) 595( ) ( ) 448( ) 444 ( ) Urban 571( ) 585( ) 577( ) Rural 627( ) 643( ) 659 ( ) Construction units 96(0 205) 108(57 159) 102 (0 219) 16

29 2.8.6 Treatment status of survey TB cases Among the 340 bacteriologically confirmed pulmonary TB cases, 106 cases (31.2%) have been diagnosed as TB and enrolled on treatment. 82.1% of them were currently having TB related symptoms. Out of 87 cases with symptoms enrolled on treatment before the survey, 59.8% was smear-positive and 40.2% was smear-negative. Health centers which provided medical service to TB or pleurisy patients in the past were city/district/county hospitals, taking a 66.1% proportion, followed by clinics (12.1%). 12.2% of TB patients were received treatment in every TB facility and level and 1% had administered self-care TB risk factors 1.27% of Among the TB patients under this TB prevalence survey, smokers were identified as survey TB cases, which1.27% compared with that of non-smokers (0.43%). The TB prevalence in smokers was 3 times higher than the proportion of survey TB cases among in non-smokers (0.43%). This result shows that smoking is one of key main risk factors for TB and explains why one of reasons for the high TB prevalence in males is much higher than. 41% of men in the one in females in the country prevalence survey reported smoking. Among the survey participants who had contact with TB case in family, 3.76% were confirmed as survey of persons had TB cases, which was patients in their family within the past two years, a rate 7.7 times higher than those who did not have a TB case inpatient within their family. 2.91% of survey participants who had infected persons were in contact with active TB case were diagnosed as survey TB case with cases, a rate of that was 6.3 times higher than those who did not have any contact with TB case in past two years. From this point of view active case finding in families having TB case should be strengthened along with chemo-prophylaxis to prevent new cases emerging and contacts with TB cases. 17

30 3 Success, challenges and lessons learnt from survey design to finalization of survey result The achieved successes of the National TB Survey is due to the National TB Control Programmes contribution of USD 481, 963 to the survey and the comparative use of less of external funds (USD from Global Fund) than other Asian countries for a successful implementation of successfully completed National TB Prevalence Survey. A high participation rate in the survey was achieved. Though the survey used paper based data collection, conventional X-ray machines and L-J solid culture for TB laboratory examination, it was conducted very scientifically with the correct final data analysis for the national TB prevalence and incidence estimation given under the close cooperation with WHO HQ. A major challenge for the National TB Prevalence Survey was the delay in the procurement of mobile conventional X-ray machines and the interrupted cash flow in the country. Thus the main survey was postponed by one year from the planned year of 2014start date. The final report preparation has taken a long time due to of lack of human resources. The lessons learnt from national TB Prevalence Survey are as follows: The planning phase is very important for the successful implementation of the survey, especially when developing the procurement plan for the capacity building of the human resources and getting the necessary laboratory and X-ray equipment and capacity building for such a survey design and data analysis. Technical assistance for countries which do not have any past survey experience is essential necessary during the survey preparation, field and operation and data analysis period. In country, the UNICEF country office Discussion of central expert committee 18

31 was responsible for processed the procurement need for the survey and WHO country office provided the technical support for protocol development, field operation, final data analysis and report preparation. Through the WHO support, technical consultant who was involved in supported the Indonesian National TB Prevalence Survey in 2016 visited DPR Korea in June 2016, reviewed survey implementation our country and provided technical support for data analysis. In the end of July 2016, two lab experts survey implementation. Data management and technical assistance from Hong Kong SNRL reviewed the laboratory progress and validated survey lab laboratory test results. In 2017, WHO HQ experts reviewed the whole survey database two times and provided the technical support for a joint survey data review and final analysis. Through open discussion and transparent collaboration with all stakeholders for the National TB Prevalence Survey, we have adopted the new TB prevalence estimates rate estimation and as a result, new baseline data has been prepared for the National Strategic Plan for TB control and the next Global Fund TB grant. 19

32 2017 National TB prevalence Democratic People s Republic of Korea

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016 NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016 Department of Health/National TB Control Program Philippine Council for Health Research and Development Foundation for the Advancement of Clinical Epidemiology,

More information

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health

National TB Prevalence survey in Myanmar. By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health National TB Prevalence survey in Myanmar By Dr. Thandar Lwin Programme Manager National TB Programme Department of Health 58 million pop. 676,577 sq km (75/sq km) S+ notification rate/100,000 population

More information

The 1 st National TB Prevalence Survey Nigeria 2012

The 1 st National TB Prevalence Survey Nigeria 2012 The 1 st National TB Prevalence Survey Nigeria 2012 Preliminary/Final Results 29 th April 2013 Dr. Joshua Obasanya NTP Manager/ PI National TB Prevalence Survey Background Indicator (2011) Population size

More information

The National TB Prevalence Survey Pakistan

The National TB Prevalence Survey Pakistan The National TB Prevalence Survey Pakistan 2010-11 Preliminary Results 29 th April 2013 Dr Ejaz Qadeer NTP Manager Principal Investigator Background Indicator (2012) Population size GNI per capita (Atlas

More information

The first National TB Prevalence Survey Rwanda 2012

The first National TB Prevalence Survey Rwanda 2012 The first National TB Prevalence Survey Rwanda 2012 Preliminary Results 29 th April 2013 Patrick Migambi Rwanda Biomedical Centre (RBC) Background Indicator (2011) Population size(census 2012) 10,537,222

More information

Protocol of National TB Prevalence Survey in Cambodia

Protocol of National TB Prevalence Survey in Cambodia Training workshop for consultants of TB prevalence surveys Protocol of National TB Prevalence Survey in Cambodia 26 February 2011 Phnom Penh, Cambodia Norio Yamada, RIT/JATA Training workshop for consultants

More information

Background paper number 7

Background paper number 7 Background paper number 7 Lessons learnt and policy implications from recently completed TB disease prevalence surveys and their interpretation - Vietnam Binh Hoa Nguyen Prevalence survey in Vietnam 2006-2007

More information

Outline. Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications

Outline. Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications MHAA Outline Milestone of survey in Myanmar Objectives Method Results Discussion Limitation Programme implications 1972 National TT survey 1994 National Sputum smear positive TB prevalence survey Protocol

More information

Report Second National Tuberculosis Prevalence Survey

Report Second National Tuberculosis Prevalence Survey Ministry of Health National Center for Tuberculosis and Leprosy Control Kingdom of Cambodia Nation Religion King Report Second National Tuberculosis Prevalence Survey December 2012 National Tuberculosis

More information

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE)

TB IN EMERGENCIES. Disease Control in Humanitarian Emergencies (DCE) TB IN EMERGENCIES Department of Epidemic and Pandemic Alert and Response (EPR) Health Security and Environment Cluster (HSE) (Acknowledgements WHO Stop TB Programme WHO/STB) 1 Why TB? >33% of the global

More information

TB Prevalence Survey. -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva

TB Prevalence Survey. -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva TB Prevalence Survey -Census, Interview and X ray- Ikushi Onozaki MD, MPH STB, WHO Geneva Census: Population & Eligibility UN estimate vs. Local estimate: Issue in CDR and burden estimate (Total: 14 mil

More information

TB Disease Prevalence Survey - Progress Report

TB Disease Prevalence Survey - Progress Report TB Disease Prevalence Survey - Progress Report 30 Oct 2011, Lille Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

More information

TB Disease Prevalence Survey - Overview and Introduction of the TF

TB Disease Prevalence Survey - Overview and Introduction of the TF TB Disease Prevalence Survey - Overview and Introduction of the TF Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int

More information

Xpert MTB/RIF assay validation experience --- impact and plan in China

Xpert MTB/RIF assay validation experience --- impact and plan in China Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE

IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE Original Article IMPACT OF IMPROVED TREATMENT SUCCESS ON THE PREVALENCE OF TB IN A RURAL COMMUNITY BASED ON ACTIVE SURVEILLANCE P. G. Gopi, R. Subramani, V. Chandrasekaran, T. Santha and P. R. Narayanan

More information

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME MINISTRY OF HEALTH UGANDA TIOL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME Revised Strategic Plan 2015/16-2019/20 Monitoring and Evaluation Plan Narrative of the Operational, Budget and Technical Assistance

More information

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Technical BRIEF Photo Credit: Challenge TB Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT Ethiopia is the second-most

More information

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor

Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Revised National Tuberculosis Control Programme (RNTCP) Dr.Kishore Yadav J Assistant Professor Global scenario*: Burden of TB Incidence : 9.6 million (58% SEAR and Western Pacific) Deaths : 1.5 million

More information

TB Disease Prevalence Survey - Overview, why and how

TB Disease Prevalence Survey - Overview, why and how TB Disease Prevalence Survey - Overview, why and how Ikushi Onozaki MD, MPH Team Leader, TB Prevalence Survey WHO Global Task Force on TB Impact Measurement Stop TB Department, WHO onozakii@who.int 3 strategic

More information

Key Words: Pulmonary Tuberculosis; Smear and Culture Findings; India METHODS

Key Words: Pulmonary Tuberculosis; Smear and Culture Findings; India METHODS Original Article EVALUATION OF BACTERIOLOGICAL DIAGNOSIS OF SMEAR POSITIVE PULMONARY TUBERCULOSIS UNDER PROGRAMME CONDITIONS IN THREE DISTRICTS IN THE CONTEXT OF DOTS IMPLEMENTATION IN INDIA C.N. Paramasivan

More information

Biology and Medicine

Biology and Medicine eissn: 09748369 Diagnosis of pulmonary tuberculosis by smear microscopy and culture in a tertiary health care facility Biology and Medicine SI Khatib, MT Williamson, R Singh, JM Joshi Accepted: 28 th Feb

More information

SURVEY FINDINGS April 28, 2017

SURVEY FINDINGS April 28, 2017 SURVEY FINDINGS April 28, 2017 Brenda Mungai Centre for Health Solutions-Kenya, TB ARC Outline Background Survey Rationale Methods Key Findings Conclusions Call to Action KENYA TUBERCULOSIS PREVALENCE

More information

National tuberculosis prevalence surveys in Asia, : an overview of results and lessons learned

National tuberculosis prevalence surveys in Asia, : an overview of results and lessons learned Tropical Medicine and International Health doi:10.1111/tmi.12534 volume 20 no 9 pp 1128 1145 september 2015 National tuberculosis prevalence surveys in Asia, 1990 2012: an overview of results and lessons

More information

Qian Gao Fudan University

Qian Gao Fudan University Qian Gao Fudan University Outline Background & Objectives Genotyping methods Establish the epidemiological field sites Preliminary results of Molecular epidemiology of TB in China Molecular epidemiology

More information

Subgroup Report Prevalence Survey. Ikushi Onozaki WHO/HQ/HTM/STB/TBS

Subgroup Report Prevalence Survey. Ikushi Onozaki WHO/HQ/HTM/STB/TBS Subgroup Report Prevalence Survey Ikushi Onozaki WHO/HQ/HTM/STB/TBS Role of sub-group Facilitate planning, implementation and reporting of National TB surveys in the 21 priority countries designated by

More information

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection? Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:

More information

Strategy for the prevention and control of Non Communicable. Diseases in the Democratic People s Republic of Korea 2014-

Strategy for the prevention and control of Non Communicable. Diseases in the Democratic People s Republic of Korea 2014- Strategy for the prevention and control of Non Communicable Diseases in the Democratic People s Republic of Korea 2014-2020 Ministry of Public Health May, 2014 Contents 1 Introduction 1. Background 2.

More information

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital Profile of Tuberculosis Infection among Current HIV+ Patients at the Albert B. Albay Jr., MD Jemylyn Garcia, MD Joel Santiaguel, MD UP- TB in the Philippines 6 th leading cause of morbidity and mortality

More information

Same-day diagnosis of tuberculosis by microscopy. Policy statement

Same-day diagnosis of tuberculosis by microscopy. Policy statement Same-day diagnosis of tuberculosis by microscopy Policy statement March 2010 Contents Abbreviations Executive summary 1. Background 2. Evidence for policy formulation 2.1 Synthesis of evidence 2.2 Management

More information

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials

Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials Prevalence of tuberculosis (TB) infection and disease among adolescents western Kenya: preparation for future TB vaccine trials Videlis Nduba 1,2, Peter Onyango 1, Anja Van t Hoog 1,3, Anthony Hawkridge

More information

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.

Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International

More information

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO

TB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information

APHL Global Health TB-related Activities

APHL Global Health TB-related Activities APHL Global Health TB-related Activities 5th National TB Conference 11-13 August 2008 San Diego, CA Travis Jobe APHL Global Health Projects Haiti Strategic planning TA & training Barbados WHO Twinning

More information

Nguyen Van Hung (NTP, Viet Nam)

Nguyen Van Hung (NTP, Viet Nam) Technical Consultation Meeting on the Programmatic Management of Latent Tuberculosis Infection 31 August-1 September 2017, Seoul, Republic Korea Adopting new LTBI diagnostics at country level: perspective

More information

TOG The Way Forward

TOG The Way Forward TOG 2016- The Way Forward Main Changes in Diagnostic algorithm Definition (Type, Classification, Outcome) Registration at the time of Diagnosis (PHI level Notification Register) Long term follow up (till

More information

PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE

PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE PROJECT AXSHYA COMMUNITY ENGAGEMENT in TB CARE An NGO-consortium initiative by World Vision India & Partners 4 th Dec 15 CSOs TB Project supported by The GFATM Round 9 grant PR: World Vision India SRs:

More information

2016 Annual Tuberculosis Report For Fresno County

2016 Annual Tuberculosis Report For Fresno County 206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis

More information

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2019, Vol. 5, Issue 2, 01-06 Research Article ISSN 2454-2229 WJPLS www.wjpls.org SJIF Impact Factor: 5.008 COMPARATIVE STUDY BETWEEN GENEXPERT MTB/RIF ASSAY AND DIRECT SMEAR MICROSCOPY(DSM) FOR

More information

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit MODULE SIX Global TB Institutions and Policy Framework Treatment Action Group TB/HIV Advocacy Toolkit 1 Topics to be Covered Global TB policy and coordinating structures The Stop TB Strategy TB/HIV collaborative

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

Costing of the Sierra Leone National Strategic Plan for TB

Costing of the Sierra Leone National Strategic Plan for TB Costing of the Sierra Leone National Strategic Plan for TB 2016-2020 Introduction The Government of Sierra Leone established the National Leprosy Control Programme in 1973 with support from the German

More information

Arizona Annual Tuberculosis Surveillance Report

Arizona Annual Tuberculosis Surveillance Report Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case

More information

Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB

Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB Prevalence Survey -Global Overview- Background, Survey results since 2007, Lessons and Implications to the program Ikushi Onozaki MD MPH WHO HQ STB TME The Global Task Force on TB Impact Measurement WHO

More information

Towards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures

Towards Harmonization of Mycobacteriology in TB Trials. Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory Procedures: Towards Harmonization of Mycobacteriology in TB Trials Title Author(s) Study 31/ACTG 5349 Key Elements of Mycobacteriology Laboratory

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Churchyard GJ, Stevens WS, Mametja LD, et al.

More information

EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD

EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD Original Article 219 EQUIVALENCE OF ACID ALONE OR ACID-ALCOHOL AS DECOLOURIZING AGENT IN ZIEHL - NEELSEN METHOD M. Gomathi Sekar, Fathima Rehman, Vanaja Kumar and N. Selvakumar (Received on 12.4.2012;

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Cain KP, McCarthy KD, Heilig CM, et al. An algorithm for tuberculosis

More information

Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China

Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China Wei et al. BMC Infectious Diseases 2014, 14:21 RESEARCH ARTICLE Open Access Changes in pulmonary tuberculosis prevalence: evidence from the 2010 population survey in a populous province of China Xiaolin

More information

Assessing the programmatic management of drug-resistant TB

Assessing the programmatic management of drug-resistant TB Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many

More information

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes

More information

TUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND

TUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND Southeast Asian J Trop Med Public Health TUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND Piyada Kunawararak 1, Sathirakorn Pongpanich 2, Sakarin Chantawong 1, Pattana

More information

SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT -

SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT - SAME-DAY-DIAGNOSIS OF TUBERCULOSIS BY MICROSCOPY - POLICY STATEMENT - March 2010 EXECUTIVE SUMMARY Direct sputum smear microscopy is the most widely used test for the diagnosis of pulmonary tuberculosis

More information

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29 Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania Childhood TB Roadmap Paris 0ctober 29 Status of childhood TB in Tanzania Child TB linkages with National

More information

TB the basics. (Dr) Margaret (DHA) and John (INZ)

TB the basics. (Dr) Margaret (DHA) and John (INZ) TB the basics (Dr) Margaret (DHA) and John (INZ) Question 1 The scientist who discovered M. tuberculosis was: A: Louis Pasteur B: Robert Koch C: Jean-Antoine Villemin D: Calmette and Guerin Question 2

More information

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

Tuberculosis Populations at Risk

Tuberculosis Populations at Risk Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading

More information

Ongoing Research on LTBI and Research priorities in India

Ongoing Research on LTBI and Research priorities in India Ongoing Research on LTBI and Research priorities in India Dr. C.Padmapriyadarsini, MD, MS ICMR-National Institute for Research in Tuberculosis Chennai, India Technical Consultation Meeting on Programmatic

More information

Communicable Disease Control Manual Chapter 4: Tuberculosis

Communicable Disease Control Manual Chapter 4: Tuberculosis Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from

More information

INDEX CASE INFORMATION

INDEX CASE INFORMATION Instructions for Completing the MDH Tuberculosis Contact Investigation Report Form Please provide as much information as possible. Each field represents information that is important to the contact investigation.

More information

The Republic of Uganda. The Uganda National Tuberculosis Prevalence Survey, Survey Report

The Republic of Uganda. The Uganda National Tuberculosis Prevalence Survey, Survey Report The Republic of Uganda The Uganda National Tuberculosis Prevalence Survey, 2014-2015 Survey Report 1 Acknowledgements Many people and institutions have contributed to the conceptualization, proposal development,

More information

Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it

Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it Angela Starks, PhD Chief, Laboratory Branch Division of TB Elimination Matt Bankowski, PhD, MS, D(ABMM), HCLD/CC(ABB)

More information

Executive Board of the United Nations Development Programme and of the United Nations Population Fund

Executive Board of the United Nations Development Programme and of the United Nations Population Fund United Nations Executive Board of the United Nations Development Programme and of the United Nations Population Fund Distr.: General 9 April 2010 Original: English DP/FPA/DCP/PRK/5 Annual session 2010

More information

New Tuberculosis Guidelines. Jason Stout, MD, MHS

New Tuberculosis Guidelines. Jason Stout, MD, MHS New Tuberculosis Guidelines Jason Stout, MD, MHS Two New Sets of Guidelines Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Diseases 2016; 63(7): e147-e195 Diagnosis of Tuberculosis in Adults

More information

572 Biomed Environ Sci, 2018; 31(8):

572 Biomed Environ Sci, 2018; 31(8): 572 Biomed Environ Sci, 2018; 31(8): 572-578 Original Article Evaluation of the New Automatic Mycob.T Stainer and Scanner for Detecting Acid-fast Bacilli in China * LI Qiang 1, ZHAO Yan Lin 2,#, WANG Qing

More information

TB Contact Investigation

TB Contact Investigation Ann Raftery, RN, PHN, MS Curry International TB Center Overview Contact investigation as a core TB control and elimination activity Components of TB Contact Investigation TB Control Priority Strategies.

More information

Report of WS on Prevalence Survey in Beijing. Norio Yamada RIT/JATA

Report of WS on Prevalence Survey in Beijing. Norio Yamada RIT/JATA Report of WS on Prevalence Survey in Beijing Norio Yamada RIT/JATA Objectives of WS To review prevalence survey recently conducted and currently planed To review and discuss TB screening methods in prevalence

More information

Action plan. Hoang Thi Thanh Thuy, MD. NTP/ National Hospital of TB and Respiratory Diseases Viet nam

Action plan. Hoang Thi Thanh Thuy, MD. NTP/ National Hospital of TB and Respiratory Diseases Viet nam Action plan Hoang Thi Thanh Thuy, MD NTP/ National Hospital of TB and Respiratory Diseases Viet nam Insurances of qualified DOTs to reduce the high defaulter rate of TB treatment in 4 mountainous districts

More information

Clinical Study Performance of Clinical Algorithms for Smear-Negative Tuberculosis in HIV-Infected PersonsinHoChiMinhCity,Vietnam

Clinical Study Performance of Clinical Algorithms for Smear-Negative Tuberculosis in HIV-Infected PersonsinHoChiMinhCity,Vietnam Tuberculosis Research and Treatment Volume 2012, Article ID 360852, 6 pages doi:10.1155/2012/360852 Clinical Study Performance of Clinical Algorithms for Smear-Negative Tuberculosis in HIV-Infected PersonsinHoChiMinhCity,Vietnam

More information

Osaka City is the third largest city (population

Osaka City is the third largest city (population Surveillance Report Strengthened tuberculosis control programme and trend of multidrug resistant tuberculosis rate in Osaka City, Japan Akira Shimouchi, a Akihiro Ohkado, a Kenji Matsumoto, b Jun Komukai,

More information

TUBERCULOSIS CONTACT INVESTIGATION

TUBERCULOSIS CONTACT INVESTIGATION TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral

More information

Analysis of TB prevalence surveys

Analysis of TB prevalence surveys Workshop and training course on TB prevalence surveys with a focus on field operations Analysis of TB prevalence surveys Day 8 Thursday, 4 August 2011 Phnom Penh Babis Sismanidis with acknowledgements

More information

Diagnosis and Medical Management of Latent TB Infection

Diagnosis and Medical Management of Latent TB Infection Diagnosis and Medical Management of Latent TB Infection Marsha Majors, RN September 7, 2017 TB Contact Investigation 101 September 6 7, 2017 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Marsha Majors,

More information

TRENDS IN THE PREVALENCE OF PULMONARY TUBERCULOSIS OVER A PERIOD OF SEVEN AND HALF YEARS IN A RURAL COMMUNITY IN SOUTH INDIA WITH

TRENDS IN THE PREVALENCE OF PULMONARY TUBERCULOSIS OVER A PERIOD OF SEVEN AND HALF YEARS IN A RURAL COMMUNITY IN SOUTH INDIA WITH 168 Original Article TRENDS IN THE PREVALENCE OF PULMONARY TUBERCULOSIS OVER A PERIOD OF SEVEN AND HALF YEARS IN A RURAL COMMUNITY IN SOUTH INDIA WITH DOTS @ C. Kolappan 1, R. Subramani 1, S. Radhakrishna

More information

Clinical Practice Guideline

Clinical Practice Guideline ITBS LTBI ITBS Management 1 of 6 ITBS Contact ITBS Oversight ITBS Disease Professional Advisory 1.0 PURPOSE: 1.1 Provide clinical practice and operational guidance to Public Health Nurses to ensure consistency

More information

TB Clinical Guidelines: Revision Highlights March 2014

TB Clinical Guidelines: Revision Highlights March 2014 TB Clinical Guidelines: Revision Highlights March 2014 AIR TRAVEL & TB CONTROL With respect to non-ambulance air travel of patients diagnosed with or suspected as having active Mycobacterium tuberculosis,

More information

DPR Korea. December Country Review DEMOCRATIC PEOPLE S REPUBLIC OF KOREA AT A GLANCE.

DPR Korea. December Country Review DEMOCRATIC PEOPLE S REPUBLIC OF KOREA AT A GLANCE. Country Review December 2010 DEMOCRATIC PEOPLE S REPUBLIC OF KOREA AT A GLANCE Total population (thousands) Annual population growth rate Population aged 15-29 (thousands) Percentage of population in urban

More information

Prevalence of Pulmonary Tuberculosis in Jutpani VDC, Chitwan, Nepal

Prevalence of Pulmonary Tuberculosis in Jutpani VDC, Chitwan, Nepal Prevalence of Pulmonary Tuberculosis in Jutpani VDC, Chitwan, Nepal Kapil Amgain and Mahendra Maharjan Central Department of Zoology, Tribhuvan University, Kirtipur, Kathmandu. For correspondence: mmaharjan@cdztu.edu.np

More information

Diagnosis and Treatment of Tuberculosis, 2011

Diagnosis and Treatment of Tuberculosis, 2011 Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is

More information

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE

COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE COMMUNITY-BASED TBHIV CASE-FINDING KENYAN EXPERIENCE Exposing a hidden epidemic Kenya TB/HIV TEAM Introduction Population: 40 million 15 th among the 22 high TB burden countries 2012: TB case notification

More information

CULTURE OR PCR WHAT IS

CULTURE OR PCR WHAT IS CULTURE OR PCR WHAT IS BEST FOR AFRICA? Peter R Mason BRTI TB IN AFRICA GLOBAL 9 MILLION NEW CASES/YR 1.5 MILLION TB DEATHS AFRICA 95% TB DEATHS IN LMIC 9/22 HIGH BURDEN COUNTRIES IN AFRICA STRONG LINK

More information

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM

ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM ANNEXURE A: EXPLANATORY NOTES ON THE DMR 164 REPORTING ON HIV AND TB FORM The form and content of the explanatory note is to: Inform those responsible for completing the DMR 164 Reporting Form - as to

More information

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION 2000 Tuberculosis Control In the WHO Western Pacific Region 2002 Report World Health Organization Office for the Western Pacific Region iii TUBERCULOSIS

More information

SARS Prevention and Control in China. Mr. Gao Qiang Executive Vice Minister of Health People s Republic of China 17 June 2003 KuaLa Lumpur

SARS Prevention and Control in China. Mr. Gao Qiang Executive Vice Minister of Health People s Republic of China 17 June 2003 KuaLa Lumpur SARS Prevention and Control in China Mr. Gao Qiang Executive Vice Minister of Health People s Republic of China 17 June 2003 KuaLa Lumpur Epidemic Situation 25 Provinces Have Reported SARS Probable Cases

More information

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis

MEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau

More information

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

1 Voluntary Counseling and Testing (for HIV) 2 Anti-retroviral Treatment

1 Voluntary Counseling and Testing (for HIV) 2 Anti-retroviral Treatment Summary 1. Outline of the Project Country: Republic of Zambia Project Title: HIV/AIDS and Tuberculosis Control Project Issue/Sector: Healthcare/population, infectious disease control Cooperation Scheme:

More information

TB Control in Finland - the role of THL

TB Control in Finland - the role of THL TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970

More information

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance

Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Workshop 04 44 th Union World Conference on Lung Health Paris, 31 October, 2013 GLOBAL TB PROGRAMME

More information

Prevalence of resistance to second-line tuberculosis drug among multidrugresistant tuberculosis patients in Viet Nam, 2011

Prevalence of resistance to second-line tuberculosis drug among multidrugresistant tuberculosis patients in Viet Nam, 2011 Original Research Prevalence of resistance to second-line tuberculosis drug among multidrugresistant tuberculosis patients in Viet Nam, 2011 Hoa Binh Nguyen, ab Nhung Viet Nguyen, ac Huong Thi Giang Tran,

More information

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos

Principle of Tuberculosis Control. CHIANG Chen-Yuan MD, MPH, DrPhilos Principle of Tuberculosis Control CHIANG Chen-Yuan MD, MPH, DrPhilos Estimated global tuberculosis burden 2015 an estimated 10.4 million incident cases of TB (range, 8.7 million 12.2 million) 142 cases

More information

Tuberculosis Control

Tuberculosis Control SEA-TB-293 Tuberculosis Control in the South-East Asia Region The Regional Report: 2006 WHO Project No: ICP TUB 001 Further publications can be obtained from: TB Unit, Department of Communicable Diseases

More information

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007

International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 TB Along the US/Mexico Border El Paso, Texas August 22-23, 2007 International Standards for Tuberculosis Care Barbara J. Seaworth, MD August 22, 2007 Barbara J Seaworth MD Medical Director Heartland National

More information

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease Self-Study Study Modules on Tuberculosis Targeted Testing and the Diagnosis of Latent Tuberculosis Infection and Tuberculosis Disease 1 Module 3: Objectives At completion of this module, learners will

More information